CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $45,534,000 | -0.0% | 386,006 | -0.0% | 0.05% | -11.5% |
| Q4 2020 | $45,535,000 | +54.2% | 386,021 | +45.4% | 0.06% | +29.8% |
| Q3 2020 | $29,523,000 | +7.9% | 265,528 | -0.8% | 0.05% | -9.6% |
| Q2 2020 | $27,350,000 | -34.7% | 267,661 | -31.1% | 0.05% | -46.4% |
| Q1 2020 | $41,903,000 | -8.5% | 388,272 | -1.7% | 0.10% | +21.2% |
| Q4 2019 | $45,809,000 | -54.1% | 394,932 | -54.7% | 0.08% | -57.0% |
| Q3 2019 | $99,783,000 | -5.4% | 871,697 | -21.2% | 0.19% | -7.0% |
| Q2 2019 | $105,463,000 | -19.4% | 1,106,636 | -22.8% | 0.20% | -16.3% |
| Q1 2019 | $130,817,000 | +22.0% | 1,433,611 | +1.5% | 0.24% | +20.7% |
| Q4 2018 | $107,191,000 | -9.8% | 1,412,488 | -4.9% | 0.20% | +3.7% |
| Q3 2018 | $118,785,000 | +69.8% | 1,484,839 | +110.8% | 0.19% | +52.8% |
| Q2 2018 | $69,966,000 | +26.9% | 704,384 | +3.4% | 0.12% | +52.4% |
| Q1 2018 | $55,155,000 | +10.2% | 680,936 | +7.2% | 0.08% | +13.9% |
| Q4 2017 | $50,048,000 | +1158.1% | 635,372 | +1373.4% | 0.07% | +1100.0% |
| Q3 2017 | $3,978,000 | – | 43,123 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
| Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
| York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
| HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
| Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
| Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
| Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
| OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
| AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |